Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Aug 31, 2026
Data as of Oct 16
- Traded
- Aug 31, 2026
- Disclosed
- Sep 1, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
+4.0%
after the sale
Similar stocks (XLV) since disclosure
+2.9%
XLV — its sector index fund
Change in closing price from Sep 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$819Kdisclosed Sep 1 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$392Kdisclosed Sep 1 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$2.2Mdisclosed Sep 1 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$404Kdisclosed Sep 1 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$348Kdisclosed Sep 1 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$304Kdisclosed Sep 1 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$20.6Kdisclosed Sep 1 · filed 1 day after the trade